BB-22

• Description :

  BB-22 is a cannabinoid wih dopamine (DA) stimulant properties. BB-22 shows affinity to CB1 receptors with a Ki value of 0.11 nM and an EC50 value of 2.9 nM[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302+H312+H332

• Target :

  Cannabinoid Receptor; Dopamine Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/bb-22.html

• Smiles :

  O=C(C1=CN(CC2CCCCC2)C3=C1C=CC=C3)OC4=C5N=CC=CC5=CC=C4

• Molecular Formula :

  C25H24N2O2

• Molecular Weight :

  384.47

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P501

• References & Citations :

  [1]De Luca MA, et al. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. Neuropharmacology. 2016 Jun;105:630-638.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1400742-42-8]